CMC2Countermeasure Command and Control
References in periodicals archive ?
The CMC2 baseline surveys collected data from 111 physicians and 3,172 patients; in CMC3, 80 physicians and 3,188 patients were included in the baseline data.
In CMC3, the question on physician discussion of PSA was only asked if the patient reported ever had a PSA test, making it incompatible with the measure in CMC2 and those of other cancer screening discussion.
Regarding discussion of a PSA test among male patients in CMC2, the base model indicated a 19 percentage point lower (overall) rate of discussion reported by Asian patients compared with whites (p<.